Stocktoria

MapLight Therapeutics, Inc. MPLT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-10-27

MapLight Therapeutics, Inc. statistics & valuation

Market cap$1.4B
P / B3.1×
Return on equity-35.2%
Return on capital-36.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-35.20% 20242025
Shares outstanding
761276 44.0M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-56.70% -33.60% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$105.38 -$18.56 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-33.6%-56.7%
Return on equity-35.2%40.1%
Current ratio20.017.20

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.